Sinomune Pharmaceutical Co., Ltd. is dedicated to R&D, manufacturing, marketing and sales of high quality pharmaceutical drugs with clinical value, focusing on the therapeutic area of Dermatology and Nephrology.
Sinomune has established a provincial
engineering technology research center and a R&D innovative team leading by
PhDs. The annual R&D investment accounts for no less than 10% of the sales
At present, the main products are competitive in topical medications and Tripterygium wilfordii field, include LiFu (Metronidazole Gel), Jinniuer（Compound Clobetasol Propionate Ointment）, Tacrolimus Ointment, Huobahuagen Tablet（Extract from Tripterygium）, Kunxian capsule，etc.